View : 557 Download: 151

Full metadata record

DC Field Value Language
dc.contributor.author서명은*
dc.date.accessioned2016-08-28T11:08:24Z-
dc.date.available2016-08-28T11:08:24Z-
dc.date.issued2000*
dc.identifier.issn0918-6158*
dc.identifier.otherOAK-388*
dc.identifier.urihttps://dspace.ewha.ac.kr/handle/2015.oak/218618-
dc.description.abstractThe cytotoxicities of pyridino[2,3-f]indole-4,9-dione derivatives were examined against human lung tumor cell lines (A 549), human ovarian tumor cell lines (SK-OV-3), human melanoma tumor cell lines (SK-MEL-2), human CNS tumor cell lines (XF 498) and human colon tumor cell lines (HCT 15) in vitro using a Sulforhodamine B assay. 3-Ethoxycarbonyl-1-(2-methoxyethyl)-2-methyl- 1H-pyridino[2,3-f]indole-4,9-dione (5) showed excellent cytotoxicity against XF 498 and HCT 15. The ED 50 values of 5 were 0.006 μg/ml against XF 498 and 0.073 μg/ml against HCT 15, while those of doxorubicin were 0.012 and 0.264 μg/ml, respectively. 1-Benzyl-3-ethoxycarbonyl-2-methyl-1H- pyridino[2,3-f]indole-4,9-dione (7) (ED 50 value 0.065 μg/ml) was also significantly more cytotoxic against HCT 15 compared with doxorubicin.*
dc.languageEnglish*
dc.titleCytotoxic effects of pyridino[2,3-f]indole-4,9-diones on human tumor cell lines*
dc.typeArticle*
dc.relation.issue3*
dc.relation.volume23*
dc.relation.indexSCI*
dc.relation.indexSCIE*
dc.relation.indexSCOPUS*
dc.relation.startpage354*
dc.relation.lastpage355*
dc.relation.journaltitleBiological and Pharmaceutical Bulletin*
dc.identifier.wosidWOS:000085696900018*
dc.identifier.scopusid2-s2.0-0342368809*
dc.author.googleSuh M.E.*
dc.author.googlePark H.-K.*
dc.author.googleYoo H.-W.*
dc.author.googleLee C.O.*
dc.contributor.scopusid서명은(7103253844)*
dc.date.modifydate20240423081003*


qrcode

BROWSE